AXPNEUTRAL

AXP P/E Ratio Analysis

20.5x

Updated 84h ago·SEC filings & market data

Key Takeaway

The P/E ratio of 20.5x means investors pay $20.50 for every $1 of the company's annual earnings per share.

Sector Performance

43th percentile

AXP

20.5x

Sector Median

23.1x

Sector Avg

33.8x

Prior Period

21.1x(Jul 2026)

↑ Improving
📊

Deep Analysis

The P/E ratio of 20.5x means investors pay $20.50 for every $1 of the company's annual earnings per share.

That is below the sector median of 23.3x, placing AXP at the 43rd percentile among peers, so it trades cheaper than most companies in its group. The year-over-year change is N/A, but the quarter-over-quarter change is -2.8%, showing the multiple has contracted from 21.1x in the prior quarter. A lower-than-median P/E combined with a recent decline suggests the market is paying less for each dollar of earnings, which can signal either a value opportunity or fading growth expectations. This level and trend point to a balanced risk profile rather than a clear edge, so the metric aligns with the overall NEUTRAL verdict.

Frequently Asked Questions

What does the P/E Ratio tell investors about AXP?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

Who are AXP's closest peers by P/E Ratio?

The closest peers by P/E Ratio include: CMCSA (7.8x), EG (7.8x), CHRD (7.7x), OXY (7.4x), THC (7.3x).

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Advertisement

Master AXP's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full AXP research report

Free account — no credit card

AXP

20.5x

Sector Median

23.1x

Sector Avg

33.8x

How AXP's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.